| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/11/2002 | WO2002028419A2 Chemokine mutants in the treatment of multiple sclerosis |
| 04/11/2002 | WO2002028418A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/11/2002 | WO2002028415A1 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 04/11/2002 | WO2002028414A1 Compositions and methods for wt1 specific immunotherapy |
| 04/11/2002 | WO2002028408A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | WO2002028407A1 Methods of recovering heat shock proteins and complexes thereof |
| 04/11/2002 | WO2002028360A2 Method for obtaining an active principle with immediate skin-tightening effect and resulting active principle |
| 04/11/2002 | WO2002028352A2 A modulator of antiestrogen pharmacology |
| 04/11/2002 | WO2002028351A2 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 04/11/2002 | WO2002028348A2 Compositions and methods for treatment of cystic fibrosis |
| 04/11/2002 | WO2002028175A2 Transgenic mouse for targeted recombination mediated by modified cre-er |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002012538A3 Nucleic acids and pathogenic e.coli proteins, and their uses |
| 04/11/2002 | WO2002012288A3 Vaccination against host cell-associated herpesviruses |
| 04/11/2002 | WO2002012275A3 Lat peptides and their use in assays for identifying immunosuppressants |
| 04/11/2002 | WO2002009649A3 Cell internalized peptide-drug conjugates |
| 04/11/2002 | WO2002007514A3 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 04/11/2002 | WO2002006789A3 Multimeric biopolymers as structural elements, sensors and actuators in microsystems |
| 04/11/2002 | WO2002006300A3 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 04/11/2002 | WO2002003911A3 Prevention and treatment of alzheimer's disease |
| 04/11/2002 | WO2002000898A9 Transformation system of fungus belonging to the genus monascus |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001096871A3 Recombinant phycobiliprotein and phycobiliprotein linker fusion proteins and uses therefore |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001091698A3 Genetically-engineered mhc molecules |
| 04/11/2002 | WO2001089559A3 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
| 04/11/2002 | WO2001089298A3 Compositions and methods of nematode control |
| 04/11/2002 | WO2001089297A3 A bioinsecticide formulation consisting of bacillus thuringiensis var israelensis, and its concerning manufacture proceedings |
| 04/11/2002 | WO2001088159A3 Cd28 synthebody for the modulation of immune responses |
| 04/11/2002 | WO2001087323A3 Method for treating cartilage disorders |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001083556A3 Retina xr receptor |
| 04/11/2002 | WO2001081602A3 Mre11 orthologue and uses thereof |
| 04/11/2002 | WO2001077353A3 Expression of pollen allergens in plastids |
| 04/11/2002 | WO2001077148A3 Human lipid binding protein 1 |
| 04/11/2002 | WO2001075107A3 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis |
| 04/11/2002 | WO2001074898A8 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 04/11/2002 | WO2001074856A3 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2001070989A3 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 04/11/2002 | WO2001070971A3 Regulation of human mas oncogene-related g protein-coupled receptor |
| 04/11/2002 | WO2001070814A3 Regulation of human rta-like g protein-coupled receptor |
| 04/11/2002 | WO2001070806A3 Human secreted proteins and polynucleotides encoding the same |
| 04/11/2002 | WO2001070174A3 Vegf-modulated genes and methods employing them |
| 04/11/2002 | WO2001068812A3 Methods of stimulating cartilage formation |
| 04/11/2002 | WO2001066574A3 Cryptococcal mannoproteins or equivalents thereof for use in modulating neutrophil migration |
| 04/11/2002 | WO2001065262A3 Reagents and methods useful for detecting diseases of the breast |
| 04/11/2002 | WO2001063294A3 Diagnosis of bipolar affective disorder (bad) and unipolar depression |
| 04/11/2002 | WO2001063293A3 Diagnosis and treatment of schizophrenia |
| 04/11/2002 | WO2001062924A3 Human g protein-coupled receptors |
| 04/11/2002 | WO2001059066A3 Protein design automation for protein libraries |
| 04/11/2002 | WO2001058946A3 Polynucleotides and polypeptides encoded thereby |
| 04/11/2002 | WO2001058937A3 Interferon-alpha induced genes |
| 04/11/2002 | WO2001057209A3 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 04/11/2002 | WO2001055320A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001055316A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001053348A3 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 04/11/2002 | WO2001051673A8 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 04/11/2002 | WO2001051511A3 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes |
| 04/11/2002 | WO2001022920A8 Colon and colon cancer associated polynucleotides and polypeptides |
| 04/11/2002 | WO2001010906A9 Crystallization and structure determination of staphylococcus aureus elongation factor p |
| 04/11/2002 | WO2000058444A9 Adaptation of virus to vertebrate cells |
| 04/11/2002 | WO2000052167A9 Angiopoietin-related protein and nucleic acids |
| 04/11/2002 | WO2000052048A9 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 04/11/2002 | WO2000042068A9 Hiv related peptides |
| 04/11/2002 | WO2000036103A9 Cytokine receptor chain |
| 04/11/2002 | WO2000034318A9 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof |
| 04/11/2002 | WO2000032774A9 12216 receptor, a g-protein coupled receptor |
| 04/11/2002 | US20020042931 Via overexpressed bicarbonate transporter; genetic engineering; plants |
| 04/11/2002 | US20020042926 Ovary-specific genes and proteins |
| 04/11/2002 | US20020042812 Apparatus, method and system for voice over a network having provider selection and disputeless billing |
| 04/11/2002 | US20020042545 Asymmetric oxidation of olefins to vicinal diol using osmium catalyst |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042504 Nucleotide sequence similar to semaphorin proteins |
| 04/11/2002 | US20020042503 Diagnosis, drug screening, clinical trial monitoring, and disease treatment |
| 04/11/2002 | US20020042502 Preparation of capped mRNA |
| 04/11/2002 | US20020042500 Bioremediation of biomass impurities; wash biomass in acidic water, incubate with enzyme, filter, sterilize and concentrate biomass to powder |
| 04/11/2002 | US20020042389 IGF-1 receptor interacting proteins |
| 04/11/2002 | US20020042386 Genetic engineering |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042382 Sequestrin |
| 04/11/2002 | US20020042378 Drug delivery; biocompatible polymer |
| 04/11/2002 | US20020042374 Method of treating insulin insensitivity and syndrome x |
| 04/11/2002 | US20020042372 Genetic engineering; central nervous system disorders |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042367 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 04/11/2002 | US20020042366 Method for treating inflammation |
| 04/11/2002 | US20020042364 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 04/11/2002 | US20020042363 Nonantigenic stabilizer and physiologically active substance |
| 04/11/2002 | US20020042362 Antiproliferative agents |
| 04/11/2002 | US20020042138 Inducing globin gene expression in cells; obtain cells, incubate with preferential nucleotide sequences, monitor cells for amplified globin expression |
| 04/11/2002 | US20020042128 Electroprocessed fibrin-based matrices and tissues |
| 04/11/2002 | US20020042127 Genetically engineered aggregation for use in the treatment of cancer |
| 04/11/2002 | US20020042126 Polypeptide for use in the diagnosis, prevention and treatment of cancer, immunological and nervous system disorders |
| 04/11/2002 | US20020042122 Mammalian proteins; related reagents and methods |
| 04/11/2002 | US20020042119 Novel Metalloproteinases |
| 04/11/2002 | US20020042113 Nucleotide sequences or use in the generation of disease resistant plants |
| 04/11/2002 | US20020042102 Synthesis without the use of the cells and their use in vivo as powerful anti-inflammatory, antithrombotic or anti-metastatic compounds |
| 04/11/2002 | US20020042100 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 04/11/2002 | US20020042096 Nucleic acids, proteins, and antibodies |